Strong Financial Performance in 2024
Alcon reported sales of $9.8 billion with above-market sales growth of 6%. Core diluted EPS grew by 16% to $3.05, and the company generated a record $1.6 billion of free cash flow.
Significant Product Pipeline and Innovations
Alcon laid the groundwork for launching one of the richest product pipelines in its history, including UNITY VCS, PanOptix Pro, and Voyager Direct Selective Laser Trabeculoplasty device.
Growth in Vision Care and Contact Lenses
Vision Care sales increased by 7% in the fourth quarter, driven by an 11% growth in contact lens sales, particularly in innovative lenses like toric and multifocal modalities.
Successful Expansion in China
Alcon experienced significant share growth in China, particularly in the ATIOL segment, contributing to stable global share despite competitive pressures in the US.